Zobrazeno 1 - 10
of 31
pro vyhledávání: '"M C Petti"'
Autor:
M, Muscaritoli, L, Conversano, M C, Petti, G F, Torelli, A, Cascino, S, Mecarocci, M A, Annicchiarico, F, Rossi Fanelli
Publikováno v:
Nutrition. 15:195-199
Changes in plasma-free amino acid (PFAA) concentrations in the presence of solid tumors have been widely described. Conversely, the PFAA profile in patients with acute leukemias is less well defined. The aim of the present study was to clarify whethe
Autor:
M Stagg, Franco Mandelli, Matthew Clarke, M. Mercier, R Alison, Françoise Huguet, Jean-Jacques Sotto, Z Tellier, Peter H. Wiernik, C Hicks, Keith Wheatley, A Tooth, Grp Amlc., V Evans, Richard Gray, Josy Reiffers, E Greaves, William R. Vogler, S James, D Wheatley, Susan M. Richards, Richard Peto, Emma Hall, V Polin, J P Dutcher, A. M. Stoppa, W R Bezwoda, M C Petti, Jean Luc Harousseau, E Berman, DA Sinclair
Publikováno v:
British Journal of Haematology. 103:100-109
A collaborative overview, using individual patient data, has been performed to compare idarubicin versus daunorubicin or other anthracyclines, when used with cytosine arabinoside as induction chemotherapy for newly diagnosed acute myeloid leukaemia.
Autor:
P. Martino, M. Venditti, A. Micozzi, G. Morace, L. Polonelli, M. P. Mantovani, M. C. Petti, V. L. Burgio, C. Santini, P. Serra, F. Mandelli
Publikováno v:
Clinical Infectious Diseases. 12:570-582
Blastoschizomyces capitatus (formerly named Trichosporon capitatum or Geotrichum capitatum) is a rare cause of invasive fungal disease in immunocompromised hosts. We retrospectively studied epidemiologic, clinical, pathologic, and microbiologic featu
Publikováno v:
Journal of experimentalclinical cancer research : CR. 25(3)
Publikováno v:
Journal of experimentalclinical cancer research : CR. 25(2)
Non-Hodgkin lymphoma of the breast is an uncommon form of lymphoma occurring either primary disease (PBL) or part of systemic involvement. We report the clinical outcome of 4 consecutive cases with CD20+ diffuse large B-cell lymphoma (DLBCL) of the b
Autor:
M C, Petti, R, Latagliata, T, Spadea, A, Spadea, E, Montefusco, M A, Aloe Spiriti, G, Avvisati, M, Breccia, E, Pescarmona, F, Mandelli
Publikováno v:
British journal of haematology. 116(3)
Between January 1985 and December 1992, 104 consecutive patients with symptomatic myelofibrosis with myeloid metaplasia (MMM) [splenic enlargement5 cm and/or transfusional requirement or Hb10 g/dl and/or white blood cell (WBC) count20 x 10(9)/l and/o
The successful use of differentiating treatment for patients with acute promyelocytic leukemia (APL) suggests that other acute myeloid leukemias (AML) may benefit from tailored and subtype-specific therapy. Despite the fact that new drugs specificall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ee2df7bd763a0e557c3a9a496a4184e8
http://hdl.handle.net/2108/161810
http://hdl.handle.net/2108/161810
Autor:
S, Keating, T, de Witte, S, Suciu, R, Willemze, M, Hayat, B, Labar, L, Resegotti, P R, Ferrini, F, Caronia, M, Dardenne, G, Solbu, M C, Petti, M L, Vegna, F, Mandelli, R A, Zittoun
Publikováno v:
British journal of haematology. 102(5)
To determine whether patients with a HLA-identical sibling donor have a better outcome than patients without a donor, an analysis on the basis of intention-to-treat principles was performed within the framework of the EORTC-GIMEMA randomized phase II
Autor:
G, Barosi, A, Ambrosetti, A, Centra, A, Falcone, C, Finelli, P, Foa, A, Grossi, R, Guarnone, S, Rupoli, L, Luciano, M C, Petti, E, Pogliani, D, Russo, M, Ruggeri, S, Quaglini
Publikováno v:
Blood. 91(10)
An unexpectedly high incidence of blast transformation after splenectomy has been reported in patients with myelofibrosis with myeloid metaplasia. However, whether this was associated with spleen removal after adjustment for risk factors was not dete
Autor:
F, Mandelli, D, Diverio, G, Avvisati, A, Luciano, T, Barbui, C, Bernasconi, G, Broccia, R, Cerri, M, Falda, G, Fioritoni, F, Leoni, V, Liso, M C, Petti, F, Rodeghiero, G, Saglio, M L, Vegna, G, Visani, U, Jehn, R, Willemze, P, Muus, P G, Pelicci, A, Biondi, F, Lo Coco
Publikováno v:
Blood. 90(3)
Two hundred fifty-three patients with newly diagnosed acute promyelocytic leukemia (APL) were eligible to enter the multicentric GIMEMA-AIEOP "AIDA" trial during the period July 1993 to February 1996. As a mandatory prerequisite for eligibility, all